Your voice

Printer-friendly version

Your views needed for, NICE Technology Appraisal.

  • Single Technology Appraisal (STA) dimethyl fumarete* for treating moderate to severe plaque psoriasis 

As an organisation we will be submitting evidence to NICE (National Institute for Health and Care Excellence)  for these appraisals and would  like you to provide your views and any experiences you have had with these and any other treatments. This could also be as a carer's point of view of someone with the condition.

It is important for us to provide views that reflect the real world of living with the condition, and any advantages and disadvantages of current treatments and these newer drugs.

* Dimethyl fumarete is a methyl ester of fumaric acid anti-inflammatory that inhibits certain functions of skin cells, namely, differentiation, proliferation and migration, as well as affecting the immune system and proliferating cells in general. It is administered orally.

To tell us your views complete the form below and click the submit button.


This question is for testing whether you are a human visitor and to prevent automated spam submissions.